KR910007920A - 3-아로일-2-옥스인돌-1-카복스아미드의 제조방법 - Google Patents

3-아로일-2-옥스인돌-1-카복스아미드의 제조방법 Download PDF

Info

Publication number
KR910007920A
KR910007920A KR1019900015777A KR900015777A KR910007920A KR 910007920 A KR910007920 A KR 910007920A KR 1019900015777 A KR1019900015777 A KR 1019900015777A KR 900015777 A KR900015777 A KR 900015777A KR 910007920 A KR910007920 A KR 910007920A
Authority
KR
South Korea
Prior art keywords
hydrogen
deuterium
tritium
chloro
compound
Prior art date
Application number
KR1019900015777A
Other languages
English (en)
Other versions
KR920010072B1 (ko
Inventor
리챠드 슐트 게리
제이콥 에어고트 프레드릭
Original Assignee
제이. 트레버 럼
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이. 트레버 럼, 화이자 인코포레이티드 filed Critical 제이. 트레버 럼
Publication of KR910007920A publication Critical patent/KR910007920A/ko
Application granted granted Critical
Publication of KR920010072B1 publication Critical patent/KR920010072B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

내용 없음.

Description

3-아로일-2-옥스인돌-1-카복스아미드의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 하기 일반식(Ⅰ)화합물을, 상기 일반식(Ⅰ)의 반응물을 기준으로 1 내지 3몰과량의 트리(저급)알킬아민을 함유하는 반응-불활성 용매중에서 수소, 중수소 또는 삼중 수소 기체 및 Pd/BaSO4촉매를 사용하여 환원성 탈할로겐화시킴을 포함하는 하기 일반식(Ⅱ)의 제조방법:
    상기식에서, X 및 Y는 각각 수소, 클로로 또는 플루오로이고; R1및 R2는각각 수소, 중수소 또는 삼중수소이며; Z는 O 또는 S이고; R3및 R4는 각각 수소, 브로모 또는 요오도이나, 단, R3및 R4중 적어도 하나는 브로모 또는 요오도이고, R1이 중수소이면, R2는 중수소 또는 수소이고, R1이 삼중수소일 때, R2는 삼중수소 또는 수소이다.
  2. 제1항에 있어서, 상기 환원성 탈할로겐화를 대기압 및 실온에서 수행하고, 상기 산 수용제가 트리에틸아민인 방법.
  3. 제2항에 있어서, X가 클로로이고, Y가 수소이며, R3및4가 각각 브로모인 방법.
  4. 제2항에 있어서, X가 플루오로이고, Y가 클로로이며, R3및4가 각각 브로모인 방법.
  5. 하기 일반식(Ⅱ)화합물 및 그의 약학적으로 허용 가능한 염기성염:
    상기식에서, X 및 Y는 각각 수소, 클로로 또는 플루오로이고; Z는 O 또는 S 이며; R1및 R2는 각각 중수소 또는 삼중수소이나, 단 R1이 중수소일 때 R2는 중수소 또는 수소이고, R1이 삼중수소일 때, R2는 삼중수소 또는 수소이며, R1및 R2중 적어도 하나는 중수소 또는 삼중수소이다.
  6. 제5항에 있어서, 5-클로로-2,3-디하이드로-3-[하이드록시-2-(4,5-디트리테오티에닐)메틸렌]-2-옥소-1H-인돌-1-카복스아미드인 화합물.
  7. 제5항에 있어서, 5-클로로-2,3-디하이드로-3-[하이드록시-2-(4,5-디듀테로티에닐)메틸렌]-2-옥소-1H-인돌-1-카복스아미드인 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900015777A 1989-10-06 1990-10-05 3-아로일-2-옥스인돌-1-카복스아미드의 제조방법 KR920010072B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/417,988 US5059693A (en) 1989-10-06 1989-10-06 Process for making 3-aroyl-2-oxindole-1-carboxamides
US417,988 1989-10-06

Publications (2)

Publication Number Publication Date
KR910007920A true KR910007920A (ko) 1991-05-30
KR920010072B1 KR920010072B1 (ko) 1992-11-13

Family

ID=23656197

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900015777A KR920010072B1 (ko) 1989-10-06 1990-10-05 3-아로일-2-옥스인돌-1-카복스아미드의 제조방법

Country Status (20)

Country Link
US (1) US5059693A (ko)
EP (1) EP0421749B1 (ko)
JP (1) JPH0710860B2 (ko)
KR (1) KR920010072B1 (ko)
AT (1) ATE131476T1 (ko)
AU (1) AU621511B2 (ko)
CA (1) CA2026974C (ko)
DE (1) DE69024159T2 (ko)
DK (1) DK0421749T3 (ko)
ES (1) ES2080811T3 (ko)
FI (1) FI102537B1 (ko)
GR (1) GR3018680T3 (ko)
HU (1) HU215841B (ko)
IE (1) IE68666B1 (ko)
IL (1) IL95831A (ko)
MY (1) MY106583A (ko)
NO (1) NO176607C (ko)
NZ (1) NZ235565A (ko)
PT (1) PT95518B (ko)
ZA (1) ZA907974B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity
HUP9600855A3 (en) * 1996-04-03 1998-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing tenidap
EP1153171A4 (en) * 1999-02-11 2004-07-07 Ingersoll Rand Co AUTOMATICALLY CONTROLLED HEATING SYSTEM FOR A PAVER
KR101677919B1 (ko) * 2015-05-07 2016-11-21 한서대학교 산학협력단 휴대용 무선 스피커 장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039591A (en) * 1975-03-20 1977-08-02 Scm Corporation Synthesis of dehydrophytol and Vitamin E
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
IN162090B (ko) * 1984-03-19 1988-03-26 Pfizer
DE3510033A1 (de) * 1985-03-20 1986-09-25 Basf Ag Verfahren zur reduktiven dehalogenierung von halogenverbindungen
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity

Also Published As

Publication number Publication date
NO176607C (no) 1995-05-03
IL95831A0 (en) 1991-06-30
FI102537B (fi) 1998-12-31
HUT59133A (en) 1992-04-28
ZA907974B (en) 1992-05-27
PT95518B (pt) 1997-07-31
ATE131476T1 (de) 1995-12-15
NZ235565A (en) 1992-02-25
PT95518A (pt) 1991-08-14
NO904334L (no) 1991-04-08
JPH03151380A (ja) 1991-06-27
AU621511B2 (en) 1992-03-12
MY106583A (en) 1995-06-30
DE69024159D1 (de) 1996-01-25
HU906357D0 (en) 1991-04-29
FI904909A0 (fi) 1990-10-05
HU215841B (hu) 1999-09-28
US5059693A (en) 1991-10-22
IE68666B1 (en) 1996-07-10
KR920010072B1 (ko) 1992-11-13
FI102537B1 (fi) 1998-12-31
IE903565A1 (en) 1991-04-10
EP0421749A2 (en) 1991-04-10
DE69024159T2 (de) 1996-05-09
GR3018680T3 (en) 1996-04-30
IL95831A (en) 1995-01-24
CA2026974A1 (en) 1991-04-07
DK0421749T3 (da) 1996-01-22
EP0421749A3 (en) 1992-01-08
CA2026974C (en) 1999-12-21
JPH0710860B2 (ja) 1995-02-08
EP0421749B1 (en) 1995-12-13
ES2080811T3 (es) 1996-02-16
AU6385690A (en) 1991-06-20
NO904334D0 (no) 1990-10-05
NO176607B (no) 1995-01-23

Similar Documents

Publication Publication Date Title
KR860003215A (ko) 4-페닐피롤 유도체의 제조방법
KR880000433A (ko) 이미다조피리딘 및 중간체 화합물의 제조방법
KR840004437A (ko) 설타미실린의 결정형 벤젠설포네이트 염의 제조방법
GB2209751A (en) Water-soluble photochromic compounds
KR840000463A (ko) 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법
KR910007920A (ko) 3-아로일-2-옥스인돌-1-카복스아미드의 제조방법
SE8307079D0 (sv) Fluorometyltiooxacefalosporiner
ATE15896T1 (de) Pyridazinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
KR850007601A (ko) 페남 유도체의 제조방법
FI932126A0 (fi) Foerfarande foer framstaellning av 2-klor-5-klormetylpyridin
KR930012741A (ko) 4-히드록시메틸테트라히드로피란의 제조방법
ATE186292T1 (de) Selektives dehalogenierungsverfahren
KR840002340A (ko) 1-(3-벤질옥시페닐)-1,1-디메틸헵탄 및 관련 중간체의 제조방법
KR840006208A (ko) 7-아닐리노이소퀴놀린-5,8-퀴논의 제조방법
KR970010772A (ko) 7-아미노-3-메톡시메틸-3-세펨-4-카르복실산의 신규 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR910011884A (ko) 아미노 글리코시드계 항생물질의 제조방법
DK0546875T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af 20-oxo-17-alpha,21-dihydroxyderivater af pregnan og mellemprodukter dertil
KR930007923A (ko) 클로르신나진 염산염의 제조방법
KR890005121A (ko) 마크롤리드 화합물의 제조방법
ATE6498T1 (de) 2,2-dichloracetoacetylchlorid und verfahren zu dessen herstellung.
KR860002473A (ko) 4-메틸-5-티오포름아미디노메틸이미다졸 디하이드로클로라이드의 제조방법
KR930012739A (ko) 디아조타입 감광체 원료의 제조방법
KR840001943A (ko) 플루오로 벤조페논 유도체 제조방법
KR950008475A (ko) N-알킬아세트아미드의 제조 방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19981106

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee